Alvotech, Dr. Reddy's ink pact for commercialisation of denosumab 0 21.05.2024 18:52 Economictimes.indiatimes.com Alvotech and Dr. Reddy's partner for AVT03, a biosimilar to Prolia and Xgeva, treating osteoporosis and skeletal-related events. The agreement includes exclusive US commercialization rights. Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
